Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID-19: Daily Top 10 Papers


  Ovarian Neoplasms

  Free Subscription


Articles published in Curr Opin Obstet Gynecol

Retrieve available abstracts of 12 articles:
HTML format



Single Articles


    February 2021
  1. WASHINGTON CR, Moore KN
    PARP inhibitors in the treatment of ovarian cancer: a review.
    Curr Opin Obstet Gynecol. 2021;33:1-6.
    PubMed     Abstract available


    December 2019
  2. WALSH CS
    Latest clinical evidence of maintenance therapy in ovarian cancer.
    Curr Opin Obstet Gynecol. 2019 Dec 10. doi: 10.1097/GCO.0000000000000592.
    PubMed     Abstract available


  3. KUBALANZA K, Konecny GE
    Mechanisms of PARP inhibitor resistance in ovarian cancer.
    Curr Opin Obstet Gynecol. 2019 Dec 6. doi: 10.1097/GCO.0000000000000600.
    PubMed     Abstract available


    February 2019
  4. MCCANN KE
    Poly-ADP-ribosyl-polymerase inhibitor resistance mechanisms and their therapeutic implications.
    Curr Opin Obstet Gynecol. 2019;31:12-17.
    PubMed     Abstract available


    December 2018
  5. STEWART D, Cristea M
    Antibody-drug conjugates for ovarian cancer: current clinical development.
    Curr Opin Obstet Gynecol. 2018 Dec 10. doi: 10.1097/GCO.0000000000000515.
    PubMed     Abstract available


    November 2018
  6. WINTERHOFF B, Talukdar S, Chang Z, Wang J, et al
    Single-cell sequencing in ovarian cancer: a new frontier in precision medicine.
    Curr Opin Obstet Gynecol. 2018 Nov 30. doi: 10.1097/GCO.0000000000000516.
    PubMed     Abstract available


  7. WASHINGTON C, Gunderson CC, Moore KN
    Update in the use and evaluation of poly (ADP-ribose) polymerase inhibitors in epithelial ovarian cancer: current and pending clinical research.
    Curr Opin Obstet Gynecol. 2018 Nov 15. doi: 10.1097/GCO.0000000000000507.
    PubMed     Abstract available


    February 2018
  8. MCCANN KE
    Novel poly-ADP-ribose polymerase inhibitor combination strategies in ovarian cancer.
    Curr Opin Obstet Gynecol. 2018;30:7-16.
    PubMed     Abstract available


  9. VOLPE J, Filipi JG, Cooper OR, Penson RT, et al
    Frontline therapy of ovarian cancer: trials and tribulations.
    Curr Opin Obstet Gynecol. 2018;30:1-6.
    PubMed     Abstract available


    November 2017
  10. PALEARI L, DeCensi A
    Endocrine therapy in ovarian cancer: where do we stand?
    Curr Opin Obstet Gynecol. 2017 Nov 14. doi: 10.1097/GCO.0000000000000423.
    PubMed     Abstract available


    November 2016
  11. KROEGER PT JR, Drapkin R
    Pathogenesis and heterogeneity of ovarian cancer.
    Curr Opin Obstet Gynecol. 2016.
    PubMed     Abstract available


    February 2016
  12. WALSH CS, Hodeib M
    Leveraging DNA repair deficiency in gynecologic oncology.
    Curr Opin Obstet Gynecol. 2016;28:24-31.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Ovarian Neoplasms is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: